Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
<p>Abstract</p> <p>Background</p> <p>Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, biomarkers of renal flare...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Theoretical Biology and Medical Modelling |
Online Access: | http://www.tbiomed.com/content/7/1/14 |
id |
doaj-a1078ba992bd4bad91f4603c544a5e2d |
---|---|
record_format |
Article |
spelling |
doaj-a1078ba992bd4bad91f4603c544a5e2d2020-11-25T00:39:10ZengBMCTheoretical Biology and Medical Modelling1742-46822010-05-01711410.1186/1742-4682-7-14Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkersBirmingham Daniel JFriedman AvnerSchugart Richard CBudu-Grajdeanu PaulaRovin Brad H<p>Abstract</p> <p>Background</p> <p>Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, biomarkers of renal flare cycle could be used to detect the onset, severity, and responsiveness of kidney relapses, and to modify therapy accordingly. However, LN is a complex disease and individual biomarkers have so far not been sufficient to accurately describe disease activity. It has been postulated that biomarkers would be more informative if integrated into a pathogenic-based model of LN.</p> <p>Results</p> <p>This work is a first attempt to integrate human LN biomarkers data into a model of kidney inflammation. Our approach is based on a system of differential equations that capture, in a simplified way, the complexity of interactions underlying disease activity. Using this model, we have been able to fit clinical urine biomarkers data from individual patients and estimate patient-specific parameters to reproduce disease dynamics, and to better understand disease mechanisms. Furthermore, our simulations suggest that the model can be used to evaluate therapeutic strategies for individual patients, or a group of patients that share similar data patterns.</p> <p>Conclusions</p> <p>We show that effective combination of clinical data and physiologically based mathematical modeling may provide a basis for more comprehensive modeling and improved clinical care for LN patients.</p> http://www.tbiomed.com/content/7/1/14 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Birmingham Daniel J Friedman Avner Schugart Richard C Budu-Grajdeanu Paula Rovin Brad H |
spellingShingle |
Birmingham Daniel J Friedman Avner Schugart Richard C Budu-Grajdeanu Paula Rovin Brad H Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers Theoretical Biology and Medical Modelling |
author_facet |
Birmingham Daniel J Friedman Avner Schugart Richard C Budu-Grajdeanu Paula Rovin Brad H |
author_sort |
Birmingham Daniel J |
title |
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers |
title_short |
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers |
title_full |
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers |
title_fullStr |
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers |
title_full_unstemmed |
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers |
title_sort |
mathematical framework for human sle nephritis: disease dynamics and urine biomarkers |
publisher |
BMC |
series |
Theoretical Biology and Medical Modelling |
issn |
1742-4682 |
publishDate |
2010-05-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, biomarkers of renal flare cycle could be used to detect the onset, severity, and responsiveness of kidney relapses, and to modify therapy accordingly. However, LN is a complex disease and individual biomarkers have so far not been sufficient to accurately describe disease activity. It has been postulated that biomarkers would be more informative if integrated into a pathogenic-based model of LN.</p> <p>Results</p> <p>This work is a first attempt to integrate human LN biomarkers data into a model of kidney inflammation. Our approach is based on a system of differential equations that capture, in a simplified way, the complexity of interactions underlying disease activity. Using this model, we have been able to fit clinical urine biomarkers data from individual patients and estimate patient-specific parameters to reproduce disease dynamics, and to better understand disease mechanisms. Furthermore, our simulations suggest that the model can be used to evaluate therapeutic strategies for individual patients, or a group of patients that share similar data patterns.</p> <p>Conclusions</p> <p>We show that effective combination of clinical data and physiologically based mathematical modeling may provide a basis for more comprehensive modeling and improved clinical care for LN patients.</p> |
url |
http://www.tbiomed.com/content/7/1/14 |
work_keys_str_mv |
AT birminghamdanielj mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers AT friedmanavner mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers AT schugartrichardc mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers AT budugrajdeanupaula mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers AT rovinbradh mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers |
_version_ |
1725294824067694592 |